Additional studies in murine models found Itaconate, an anti-inflammatory mitochondrial metabolite produced by macrophages and monocytes, achieved protection against AAA formation via agonistic effects on the Nrf2 pathway and inhibition of the NLRP3 inflammasome [71]. This evidence concerns the gene NLRP3 and triple-A syndrome.